HEADER TRANSFERASE/TRANSFERASE INHIBITOR 21-APR-13 4K9Y TITLE FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-[4-(6-AMINO- TITLE 2 PURIN-9-YL)-PHENYL]-3-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-UREA COMPND MOL_ID: 1; COMPND 2 MOLECULE: FOCAL ADHESION KINASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: FADK 1, FOCAL ADHESION KINASE-RELATED NONKINASE, FRNK, COMPND 6 PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 71, PPP1R71, PROTEIN- COMPND 7 TYROSINE KINASE 2, P125FAK, PP125FAK; COMPND 8 EC: 2.7.10.2; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTK2, FAK, FAK1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS TYROSINE PROTEIN KINASE, TRANSFERASE, ATP BINDING, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.MUSIL,U.GRAEDLER,M.LEHMANN,T.HEINRICH,V.DRESING REVDAT 2 09-OCT-13 4K9Y 1 JRNL REVDAT 1 11-SEP-13 4K9Y 0 JRNL AUTH U.GRADLER,J.BOMKE,D.MUSIL,V.DRESING,M.LEHMANN,G.HOLZEMANN, JRNL AUTH 2 H.GREINER,C.ESDAR,M.KRIER,T.HEINRICH JRNL TITL FRAGMENT-BASED DISCOVERY OF FOCAL ADHESION KINASE JRNL TITL 2 INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 5401 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23973211 JRNL DOI 10.1016/J.BMCL.2013.07.050 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 33657 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1683 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.17 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2822 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1859 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2681 REMARK 3 BIN R VALUE (WORKING SET) : 0.1846 REMARK 3 BIN FREE R VALUE : 0.2113 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 141 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2180 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 253 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.99 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.38260 REMARK 3 B22 (A**2) : 1.18050 REMARK 3 B33 (A**2) : 0.20210 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.97950 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.11 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2294 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3110 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 810 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 51 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 334 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2294 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 289 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2773 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.22 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.14 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|415 - A|685 } REMARK 3 ORIGIN FOR THE GROUP (A): -17.0507 -28.7926 8.8212 REMARK 3 T TENSOR REMARK 3 T11: -0.0520 T22: -0.0626 REMARK 3 T33: -0.0496 T12: -0.0102 REMARK 3 T13: 0.0122 T23: 0.0084 REMARK 3 L TENSOR REMARK 3 L11: 1.0893 L22: 0.6725 REMARK 3 L33: 1.2086 L12: -0.0651 REMARK 3 L13: 0.6112 L23: 0.0828 REMARK 3 S TENSOR REMARK 3 S11: 0.0041 S12: -0.0578 S13: 0.0120 REMARK 3 S21: 0.0064 S22: -0.0111 S23: 0.1311 REMARK 3 S31: -0.0259 S32: 0.1256 S33: 0.0070 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4K9Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-APR-13. REMARK 100 THE RCSB ID CODE IS RCSB079076. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : FLAT PANEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33672 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 42.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.43900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, 4.3 M NACL, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 67.39500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.88500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 67.39500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.88500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1034 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 408 REMARK 465 SER A 409 REMARK 465 PRO A 410 REMARK 465 SER A 411 REMARK 465 THR A 412 REMARK 465 ARG A 413 REMARK 465 ASP A 414 REMARK 465 GLN A 686 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 545 -11.87 80.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K9Y A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4GU6 RELATED DB: PDB REMARK 900 RELATED ID: 4GU9 RELATED DB: PDB REMARK 900 RELATED ID: 4K8A RELATED DB: PDB REMARK 900 RELATED ID: 4KAB RELATED DB: PDB REMARK 900 RELATED ID: 4KAO RELATED DB: PDB DBREF 4K9Y A 410 686 UNP Q05397 FAK1_HUMAN 410 686 SEQADV 4K9Y GLY A 408 UNP Q05397 EXPRESSION TAG SEQADV 4K9Y SER A 409 UNP Q05397 EXPRESSION TAG SEQRES 1 A 279 GLY SER PRO SER THR ARG ASP TYR GLU ILE GLN ARG GLU SEQRES 2 A 279 ARG ILE GLU LEU GLY ARG CYS ILE GLY GLU GLY GLN PHE SEQRES 3 A 279 GLY ASP VAL HIS GLN GLY ILE TYR MET SER PRO GLU ASN SEQRES 4 A 279 PRO ALA LEU ALA VAL ALA ILE LYS THR CYS LYS ASN CYS SEQRES 5 A 279 THR SER ASP SER VAL ARG GLU LYS PHE LEU GLN GLU ALA SEQRES 6 A 279 LEU THR MET ARG GLN PHE ASP HIS PRO HIS ILE VAL LYS SEQRES 7 A 279 LEU ILE GLY VAL ILE THR GLU ASN PRO VAL TRP ILE ILE SEQRES 8 A 279 MET GLU LEU CYS THR LEU GLY GLU LEU ARG SER PHE LEU SEQRES 9 A 279 GLN VAL ARG LYS TYR SER LEU ASP LEU ALA SER LEU ILE SEQRES 10 A 279 LEU TYR ALA TYR GLN LEU SER THR ALA LEU ALA TYR LEU SEQRES 11 A 279 GLU SER LYS ARG PHE VAL HIS ARG ASP ILE ALA ALA ARG SEQRES 12 A 279 ASN VAL LEU VAL SER SER ASN ASP CYS VAL LYS LEU GLY SEQRES 13 A 279 ASP PHE GLY LEU SER ARG TYR MET GLU ASP SER THR TYR SEQRES 14 A 279 TYR LYS ALA SER LYS GLY LYS LEU PRO ILE LYS TRP MET SEQRES 15 A 279 ALA PRO GLU SER ILE ASN PHE ARG ARG PHE THR SER ALA SEQRES 16 A 279 SER ASP VAL TRP MET PHE GLY VAL CYS MET TRP GLU ILE SEQRES 17 A 279 LEU MET HIS GLY VAL LYS PRO PHE GLN GLY VAL LYS ASN SEQRES 18 A 279 ASN ASP VAL ILE GLY ARG ILE GLU ASN GLY GLU ARG LEU SEQRES 19 A 279 PRO MET PRO PRO ASN CYS PRO PRO THR LEU TYR SER LEU SEQRES 20 A 279 MET THR LYS CYS TRP ALA TYR ASP PRO SER ARG ARG PRO SEQRES 21 A 279 ARG PHE THR GLU LEU LYS ALA GLN LEU SER THR ILE LEU SEQRES 22 A 279 GLU GLU GLU LYS ALA GLN HET K9Y A 701 36 HETNAM K9Y 1-[4-(6-AMINO-9H-PURIN-9-YL)PHENYL]-3-[3-TERT-BUTYL-1- HETNAM 2 K9Y (4-METHYLPHENYL)-1H-PYRAZOL-5-YL]UREA FORMUL 2 K9Y C26 H27 N9 O FORMUL 3 HOH *253(H2 O) HELIX 1 1 GLN A 418 GLU A 420 5 3 HELIX 2 2 SER A 461 ARG A 476 1 16 HELIX 3 3 LEU A 507 ARG A 514 1 8 HELIX 4 4 ASP A 519 LYS A 540 1 22 HELIX 5 5 ALA A 548 ARG A 550 5 3 HELIX 6 6 GLY A 566 TYR A 570 5 5 HELIX 7 7 ASP A 573 LYS A 581 1 9 HELIX 8 8 ALA A 590 ARG A 597 1 8 HELIX 9 9 THR A 600 MET A 617 1 18 HELIX 10 10 LYS A 627 ASN A 637 1 11 HELIX 11 11 PRO A 648 TRP A 659 1 12 HELIX 12 12 ASP A 662 ARG A 666 5 5 HELIX 13 13 ARG A 668 ALA A 685 1 18 SHEET 1 A 5 ILE A 422 GLY A 429 0 SHEET 2 A 5 VAL A 436 TYR A 441 -1 O ILE A 440 N GLU A 423 SHEET 3 A 5 LEU A 449 THR A 455 -1 O ILE A 453 N HIS A 437 SHEET 4 A 5 TRP A 496 GLU A 500 -1 O MET A 499 N ALA A 452 SHEET 5 A 5 LEU A 486 ILE A 490 -1 N GLY A 488 O ILE A 498 SHEET 1 B 3 GLY A 505 GLU A 506 0 SHEET 2 B 3 VAL A 552 SER A 556 -1 O VAL A 554 N GLY A 505 SHEET 3 B 3 CYS A 559 LEU A 562 -1 O LYS A 561 N LEU A 553 SSBOND 1 CYS A 456 CYS A 459 1555 1555 2.03 CISPEP 1 ASN A 493 PRO A 494 0 -3.55 SITE 1 AC1 18 ILE A 428 GLU A 471 MET A 475 VAL A 484 SITE 2 AC1 18 MET A 499 GLU A 500 CYS A 502 PHE A 542 SITE 3 AC1 18 LEU A 553 GLY A 563 ASP A 564 PHE A 565 SITE 4 AC1 18 ARG A 569 TYR A 570 HOH A 828 HOH A 843 SITE 5 AC1 18 HOH A 866 HOH A 927 CRYST1 134.790 61.770 61.900 90.00 100.50 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007419 0.000000 0.001375 0.00000 SCALE2 0.000000 0.016189 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016430 0.00000